Oxcarbazepine add-on for drug-resistant partial epilepsy

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 11, 2016, Pages

  Castillo, Sergio M ^a   Schmidt, Dieter B ^b   White, Sarah ^c   Shukralla, Arif ^d  

^a HOSPITAL DEL SALVADOR   (Chile)

^b Epilepsy Research Group   (Germany)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OXCARBAZEPINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE;

ARTICLE; DRUG RESISTANT EPILEPSY; FOCAL EPILEPSY; MEDICAL LITERATURE; PRIORITY JOURNAL; PUBLICATION; SYSTEMATIC REVIEW; ADULT; ANALOGS AND DERIVATIVES; CHILD; COMBINATION DRUG THERAPY; DRUG RESISTANCE; EPILEPSIES, PARTIAL; HUMAN; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84997171056     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002028.pub2     Document Type: Article

References (14)

1. Glauser T, Nigro M, Sachdeo R, Bibas Bonet H, et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. [4295759]
2. Halasz P, Walker EB, Elger CE, Scaramelli A, et al. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. [4295761]
3. Houtkooper MA, Lammertsma A, Meyer JWA, Goedhart DM, Meinardi H, et al. Oxcarbazepine (GP 47.680): a possible alternative to carbamazepine?. Epilepsia 1987;28(6):693-8. [4295762]
4. Pina-Garza JE, Espinoza R, Nordli D, Bennett DA, Spirito S, Stites TE, et al. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology 2005;65:1370-5. [4295763]
5. Atim-Oluk M, Jackson CF, Marson AG. Oxcarbazepine add-on for drug-resistant partial epilepsy. Cochrane Database of Systematic Reviews 2016, Issue 11. [DOI: 10.1002/14651858.CD012433]
6. Cochrane HC, Baker GA, Chadwick DW. Neuropsychological outcomes in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards. Epilepsia 1998;39(10):1088-97.
7. Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30(4):389-99.
8. Grant SM, Faulds D. Oxcarbazepine: a review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders. Drugs 1992;43(6):873-8.
9. Kunz R, Oxman AD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. British Medical Journal 1998;317:1185-90.
10. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38(8):859-80.
11. McCullagh P, Nelder JA. Generalized linear models. 2nd Edition. London: Chapman and Hall, 1989.
12. Privitera MD. Evidence-based medicine and antiepileptic drugs. Epilepsia 1999;40(Suppl 5):S47-S56.
13. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273(5):408-12.
14. Walker MC, Sander JW. Difficulties in extrapolating from clinical trial data to clinical practice: the case of antiepileptic drugs. Journal of Neurology 1997;49:333-7.